MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma	https://doi.org/10.1073/pnas.1009719107	2010	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis	https://doi.org/10.1016/j.yexmp.2015.03.006	2015	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
MicroRNA profiling in human medulloblastoma.	https://doi.org/10.1002/ijc.23948	2008	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 10 Master/Detail View
Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma.	https://doi.org/10.1007/s11060-008-9624-3	2008	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.	https://doi.org/10.1093/neuonc/noq179	2011	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma.	https://doi.org/10.3389/fonc.2013.00254	2013	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4	https://doi.org/10.1016/j.biopha.2015.08.012	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16	https://doi.org/10.1159/000438575	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4	https://doi.org/10.1177/1010428317703841	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway	https://doi.org/10.26355/eurrev_201905_17783	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo	https://doi.org/10.1002/1873-3468.13387	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA	https://doi.org/MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-181d-5p-FOXP1 feedback loop modulates the progression of osteosarcoma	https://doi.org/10.1016/j.bbrc.2018.07.060	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of ?-catenin/LEF1 complex via effects on chromatin remodeling	https://doi.org/10.1186/s12943-019-1076-1	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma	https://doi.org/10.1177/2058738418820743	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN	https://doi.org/10.3892/or.2016.4719	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-548d-3p inhibits osteosarcoma by downregulating KRAS	https://doi.org/10.18632/aging.102097	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2	https://doi.org/10.1007/s13277-015-3568-y	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients	https://doi.org/10.1016/j.prp.2019.152686	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma	https://doi.org/10.1016/j.febslet.2013.03.007	2013	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications